New Providence, NJ, United States of America

Anthony J Tutino

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 62(Granted Patents)


Company Filing History:


Years Active: 2013-2020

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Anthony J Tutino

Introduction

Anthony J Tutino is a notable inventor based in New Providence, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 7 patents. His work focuses on developing formulations that address various medical conditions, including cancer and inflammatory diseases.

Latest Patents

Among his latest patents are formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione. These patents include pharmaceutical compositions and single unit dosage forms of this compound, or its pharmaceutically acceptable stereoisomers, prodrugs, salts, solvates, hydrates, or clathrates. The patents also detail methods for treating, managing, or preventing various disorders, such as cancer or inflammatory diseases.

Career Highlights

Anthony has worked with prominent companies in the pharmaceutical industry, including Celgene Corporation and Signal Pharmaceuticals, Inc. His experience in these organizations has allowed him to develop innovative solutions that contribute to advancements in medical treatments.

Collaborations

Throughout his career, Anthony has collaborated with esteemed colleagues, including Michael T Kelly and Sreenivas S Bhat. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical solutions.

Conclusion

Anthony J Tutino's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to improving healthcare. His work continues to pave the way for advancements in the treatment of serious medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…